about
Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair.Enhanced adenoviral-vector mediated gene transfer using human albumin solder.Multiplexed supramolecular self-assembly for non-viral gene delivery.Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013.Gene therapy for cerebral vascular disease: update 2003.Misconduct in medical research: whose responsibility?Development of herpesvirus-based episomally maintained gene delivery vectors.Gene therapeutics: the future of brain tumor therapy?Gene therapy: the end of the rainbow?RNAi Therapeutic Platforms for Lung Diseases.Antisense gene silencing: therapy for neurodegenerative disorders?Gene therapy oversight: lessons for nanobiotechnology.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.Cell-mediated and direct gene therapy for bone regeneration.Current gene therapy trials for vascular diseases.Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression.A nonviral vector with transfection activity comparable with adenoviral transduction.Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats.Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats.Seeing the gene therapy: application of gene gun technique to transfect and decolour pigmented rat skin with human agouti signalling protein cDNA.Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway.
P2860
Q30429011-E4E5279D-2936-4288-9C2F-F49EC87FAE9AQ32081179-F63905EE-AA64-4956-9EEC-5F1030D1DAB8Q33683023-0C727E1C-B3FD-4C02-8DED-5F69FECF48B8Q33782832-9A3A45D7-3491-46EA-9776-98A460E03F2DQ35045240-1F795019-8DFD-4601-9542-2D8B8D52485AQ35101662-D9744E6C-E647-4752-ADB7-723412D6F28EQ35753517-ED507282-E49D-4F8E-9B29-EC2B10328528Q36532106-6743057C-A140-4C0B-A672-1020ECB262DEQ37158534-E73F8C80-45DF-4625-9A7B-06C54F2F918BQ37277373-BF1BE746-BA9D-46E0-967C-F3C2F0D5123DQ37585001-74B510AC-9DC0-451A-B54F-CA1B4D368135Q37685270-D62FE9C8-0923-4219-B509-2B121E5F568CQ37849777-85CAB3CC-2684-43E9-9ADE-E75613973BE5Q37983112-5E1F5FCA-E4E2-47FA-BA7D-DE38B989C368Q38175483-09D6B683-6C08-4DBC-8699-CEED275F4F09Q38424720-F7160FD8-E26D-425E-923A-9E5A197B5AB9Q39601760-8C611D74-2006-4ABC-A372-294AF50DCBE9Q40173334-3301DC39-6C04-490B-9194-686D1B19B556Q40478238-506FBC14-82E2-4631-8E47-472BE7CD303BQ44052702-30C709B1-98F2-4890-80F1-CECD5CD6F2D3Q44872856-BFFA5627-646A-4B55-8286-A152B8F7338BQ44911292-107CCDC4-286B-4C49-8EC3-D8928E668AF7Q45884349-AF267283-A9DD-49E7-A1F3-9BCFC1D9EC64
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
US gene therapy in crisis.
@en
US gene therapy in crisis.
@nl
type
label
US gene therapy in crisis.
@en
US gene therapy in crisis.
@nl
prefLabel
US gene therapy in crisis.
@en
US gene therapy in crisis.
@nl
P1433
P1476
US gene therapy in crisis.
@en
P2093
Teichler Zallen D
P304
P356
10.1016/S0168-9525(00)02025-4
P577
2000-06-01T00:00:00Z